Search results for "amine"

showing 10 items of 7299 documents

Adult attachment and gene polymorphisms of the dopamine D4 receptor and serotonin transporter (5-HTT).

2010

Recently, the Dopamine D4 Receptor Gene (DRD4) and the Serotonin Transporter Gene (5-HTT) have been found to be candidate genes for infant attachment disorganization. The present study aimed to explore the relationship of these genes to adult attachment representations. The Adult Attachment Interview was used to assess attachment representations in 167 German adults. DNA from buccal cells was genotyped for the DRD4 VNTR Exon III and 5-HTT LPR polymorphisms with respect to the presence of the 7repeat allele and the short allele, respectively. DRD4 7repeat allele carriers were significantly more likely to be securely attached than those without 7repeat but only for subjects with unloving care…

AdultMalemedicine.medical_specialtyCandidate geneGenotypePsychometricsStatistics as TopicExonDopamineRisk Factorsmental disordersInterview PsychologicalDevelopmental and Educational PsychologymedicineAttachment theoryHumansAllelePsychiatryGeneSerotonin transporterRetrospective StudiesGeneticsSerotonin Plasma Membrane Transport ProteinsPolymorphism GeneticbiologyReceptors Dopamine D4Middle AgedObject AttachmentPsychiatry and Mental healthCross-Sectional StudiesPhenotypebiology.proteinFemalePsychologyAttachment measuresmedicine.drugAttachmenthuman development
researchProduct

Effects of Clomipramine on Sleep EEG and Nocturnal Penile Tumescence

1988

The effects of the tricyclic antidepressant clomipramine on sleep EEG and nocturnal penile tumescence (NPT) were investigated during a long-term study in a normal male control subject. During 21 consecutive days the subject received first placebo for 3 days, then stepwise increasing dosages of clomipramine for 10 days, and finally placebo after withdrawal for 8 days. Under clomipramine, rapid eye movement (REM) sleep was suppressed markedly; an REM rebound occurred after withdrawal. Awake and stages 1 and 2 increased while slow wave sleep was diminished under clomipramine. Those non-REM parameters returned to baseline values after drug cessation. NPT was reduced simultaneously with REM slee…

AdultMalemedicine.medical_specialtyClomipramineEjaculationSexual BehaviorRapid eye movement sleepPlaceboREM reboundInternal medicinemedicineHumansPharmacology (medical)Slow-wave sleepPenile ErectionElectroencephalographymedicine.diseasePsychiatry and Mental healthEndocrinologyErectile dysfunctionNocturnal penile tumescenceAnesthesiaClomipramineSleepPsychologymedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomog…

2007

The telencephalic dopamine innervations contribute to the modulation of cognitive processing. However, the relationship between cognitive effects of D(2/3)-receptor antagonism and dopamine transmission is not described in healthy subjects. We therefore tested effects of acute haloperidol (5 mg/d over 3 days) on continuous performance task (CPT) performance and 6-[(18)F]-fluoro-l-DOPA (FDOPA) PET parameters. Nine physically and mentally healthy male men performed two FDOPA-PET scans including arterial plasma withdrawal. Over 3 days before the second scan, all subjects were treated with 5 mg/d haloperidol orally. Using our novel steady-state analysis, we calculated the intrinsic rate of the c…

AdultMalemedicine.medical_specialtyCognitive NeuroscienceDopamineKineticsStriatumNeuropsychological TestsCognitionDopamineContinuous performance taskFluorodeoxyglucose F18Predictive Value of TestsInternal medicinemedicineHaloperidolImage Processing Computer-AssistedHumansEffects of sleep deprivation on cognitive performancePsychiatryBrain Chemistrymedicine.diagnostic_testHealthy subjectsReceptors Dopamine D3BrainMiddle AgedDopamine D2 Receptor AntagonistsEndocrinologyNeurologyPositron emission tomographyData Interpretation StatisticalPositron-Emission TomographyDopamine AntagonistsHaloperidolFemaleRadiopharmaceuticalsPsychologyAlgorithmsPsychomotor Performancemedicine.drugNeuroImage
researchProduct

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.

2003

The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This study indicates that gabapentin should be considered as a treatment option for the neuropathic pain of Fabry disease.

AdultMalemedicine.medical_specialtyDiabetic neuropathyGabapentinAdolescentCyclohexanecarboxylic Acidsmedicine.medical_treatmentAcetatesGeneticsmedicineHumansBrief Pain InventoryAminesGenetics (clinical)gamma-Aminobutyric AcidPain Measurementbusiness.industryVascular diseaseEnzyme replacement therapymedicine.diseaseFabry diseaseSurgeryAnticonvulsantTreatment OutcomeAnesthesiaNeuropathic painFabry DiseaseNeuralgiaAnticonvulsantsGabapentinbusinessmedicine.drugJournal of inherited metabolic disease
researchProduct

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. …

2009

Combining measurements of the monoamine metabolites in the cerebrospinal fluid (CSF) and neuroimaging can increase efficiency of drug discovery for treatment of brain disorders. To address this question, we examined five drug-naive patients suffering from schizophrenic disorder. Patients were assessed clinically, using the Positive and Negative Syndrome Scale (PANSS): at baseline and then at weekly intervals. Plasma and CSF levels of quetiapine and norquetiapine as well CSF 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindole-acetic acid (5-HIAA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) were obtained at baseline and again after at least a 4 week medication trai…

AdultMalemedicine.medical_specialtyDibenzothiazepinesFluorine RadioisotopesPyrrolidinesmedicine.drug_classCaudate nucleusAtypical antipsychoticPilot ProjectsTritiumMethoxyhydroxyphenylglycolchemistry.chemical_compoundQuetiapine FumarateYoung AdultInternal medicinemedicineHumansBiogenic MonoaminesBiological PsychiatryTemporal cortexFirst episodeBrain Mappingbusiness.industryReceptors Dopamine D2Homovanillic acidHomovanillic AcidMiddle AgedMagnetic Resonance ImagingPsychiatry and Mental healthMonoamine neurotransmitterEndocrinologyFallypridechemistryPositron-Emission TomographyBenzamidesSchizophreniaQuetiapine34-Dihydroxyphenylacetic Acidbusinessmedicine.drugAntipsychotic AgentsProtein BindingJournal of psychiatric research
researchProduct

A Narrative Review about Nutritional Management and Prevention of Oral Mucositis in Haematology and Oncology Cancer Patients Undergoing Antineoplasti…

2021

Cancer is a prevalent disease worldwide, and treatments such as radiotherapy and chemotherapy sometimes lead to adverse events. Oral mucositis is one of the most disabling adverse events, and clinical guidelines do not take into account nutritional interventions. The primary endpoint was to gather the evidence about the efficacy of nutritional interventions in the prevention and/or treatment of antineoplastic-induced oral mucositis in oncological patients. A bibliographic review was carried out in the PubMed data base by combining MeSH terms with Boolean operators. Articles were selected based on inclusion and exclusion criteria; 50 final articles were found. Although further evidence is ne…

AdultMalemedicine.medical_specialtyDiet therapyGlutaminemedicine.medical_treatmentAntineoplastic AgentsReviewDiseaseNeoplasmsmedicineMucositisClinical endpointHumanscancerTX341-641ChildAdverse effectIntensive care medicineStomatitisNutrition and DieteticsNutrition. Foods and food supplybusiness.industryCancerHoneyVitaminsmedicine.diseaseRadiation therapyTreatment Outcomediet therapyDietary SupplementsInclusion and exclusion criteriaFemalebusinessoral mucositisFood ScienceNutrients
researchProduct

Serum Concentrations of Fluvoxamine and Clinical Effects: A prospective open clinical trial

1998

This pilot study examined prospectively blood serum concentrations of fluvoxamine, side effects and therapeutic response after a fixed dosage of 100 mg fluvoxamine/day for 14 days. Twenty male and female patients who met the DSM-IV criteria of a major depression received 50 mg fluvoxamine b.i.d. for two weeks. On days 7 and 14 side effects and therapeutic response were registered and serum concentrations of fluvoxamine were determined. A Receiver Operating Characteristic (ROC) curve was constructed to determine a possible relationship between serum concentrations and clinical effects. The serum concentrations of fluvoxamine were highly variable, even when dosages were corrected for body wei…

AdultMalemedicine.medical_specialtyDosemedicine.medical_treatmentFluvoxamineGastroenterologyBlood serumInternal medicinemedicineHumansPharmacology (medical)Prospective StudiesAgedAged 80 and overDepressive DisorderChemotherapymedicine.diagnostic_testReceiver operating characteristicbusiness.industryGeneral MedicineMiddle AgedClinical trialPsychiatry and Mental healthROC CurveFluvoxamineTherapeutic drug monitoringAnesthesiaAntidepressive Agents Second-GenerationFemaleDrug MonitoringbusinessReuptake inhibitormedicine.drugPharmacopsychiatry
researchProduct

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.

2005

Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS). Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions. Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female). Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS. For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied a…

AdultMalemedicine.medical_specialtyDyskinesia Drug-InducedAdolescentmedicine.drug_classStatistics as TopicAtypical antipsychoticPharmacologyGastroenterologyExtrapyramidal symptomsInternal medicineGermanymedicineHumansAmisulprideBiological PsychiatryAgedRetrospective StudiesAged 80 and overNeurologic ExaminationPsychiatric Status Rating ScalesReceiver operating characteristicmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryDopamine antagonistMiddle Agedmedicine.diseasePsychiatry and Mental healthDose–response relationshipROC CurveSchizophreniaTherapeutic drug monitoringSchizophreniaFemalemedicine.symptomAmisulprideDrug MonitoringSulpiridebusinessmedicine.drugAntipsychotic AgentsJournal of psychiatric research
researchProduct

Night-rest urinary catecholamine excretion in relation to aspects of free time, work and background data in a teacher group

1991

Free time, work and background data were related to night-rest catecholamine excretion rates in a teacher group (n = 137) during an autumn term. The explained interindividual variance increased slightly towards the end of the term. Adrenaline excretion was predicted better than noradrenaline, notedly by coffee consumption, amount of physical activity, and subjective stress feelings which explained 16% of the variance in adrenaline excretion during night rest. However, the results indicated that the differences in catecholamine excretion during night rest remained mostly unpredictable.

AdultMalemedicine.medical_specialtyEpinephrineIndividualityCoffee consumptionUrineAnxietyJob SatisfactionExcretionNorepinephrinechemistry.chemical_compoundLeisure ActivitiesArts and Humanities (miscellaneous)Internal medicineUrinary catecholamineDevelopmental and Educational PsychologymedicineHumansGeneral PsychologyDepressionTeachingBackground dataGeneral MedicineCircadian RhythmEndocrinologyEpinephrinechemistryCatecholamineFemaleArousalSleepPsychologyCaffeinemedicine.drugScandinavian Journal of Psychology
researchProduct

Plasma catecholamine responses and neural adaptation during short-term resistance training

2000

Low exercise-induced plasma adrenaline (A) responses have been reported in resistance-trained indi- viduals. In the study reported here, we investigated the interaction between strength gain and neural adaptation of the muscles, and the plasma A response in eight healthy men during a short-term resistance-training period. The subjects performed 5 resistance exercises (E1-E5), consisting of 6 sets of 12 bilateral leg exten- sions performed at a 50% load, and with 2 days rest in between. Average electromyographic (EMG) signal amplitude was recorded before and after the exercises, from the knee extensor muscles in isometric maximal voluntary contraction (MVC) as well as during the exercises (a…

AdultMalemedicine.medical_specialtyEpinephrineKnee JointPhysiologyPhysical exerciseIsometric exerciseElectromyographyNorepinephrineOxygen ConsumptionIsometric ContractionPhysiology (medical)Internal medicineStatistical significanceBlood plasmamedicineHumansOrthopedics and Sports MedicineLactic AcidMuscle SkeletalExerciseLegmedicine.diagnostic_testElectromyographybusiness.industryNeural adaptationPublic Health Environmental and Occupational HealthGeneral MedicineAdaptation PhysiologicalSurgerymedicine.anatomical_structureEndocrinologyCatecholaminemedicine.symptombusinessmedicine.drugMuscle contractionEuropean Journal of Applied Physiology
researchProduct